top of page
Latest News
BioCentury Grand Rounds
Ascensus Therapeutics was invited to present at the BioCentury Grand Rounds meeting in Nashville, TN.
Sachs Oncology Innovation Forum
Ascensus Therapeutics was invited to present the novel approach and recent progress developed at the 11th Annual Oncology Innovation Forum.
Clearance to Initiate First-in-
Human Clinical Trial
Ascensus Therapeutics has received regulatory clearance to begin its first-in-human Phase I/IIa clinical trial of its lead cell therapy for adenocarcinoma. The study will evaluate safety and early biological activity in patients with advanced disease.
bottom of page